Development and validation of a novel HER2RI assay for predicting the risk of recurrence and survival in HER2-positive early breast cancer

作者：Yi‐Kun Kang, Keyu Chen, Singlin Gao, Xiaojia Wang, Xue Wang, Jian Yue, Ouchen Wang, Jianmin Li, Huimin Wang, Ting‐Hao Chen, Furong Du, Shangzhi Cao, Binghe Xu, Peng Yuan · 发表于：Research Square · 年份：2022 · DOI：10.21203/rs.3.rs-1964372/v1 · 研究领域：HER2/EGFR in Cancer Research、Breast Cancer Treatment Studies、Cancer Cells and Metastasis